Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Chill Brands GroupLSE:CHLL 3-Year EBITDA Growth Rate is 31.30% as of Mar. 2026, which is 61% above its 10-year median of 19.40. The stock has 5 warning signs investors should review. Among 808 Drug Manufacturers companies, Chill Brands Group ranks better than 79.33% on this metric.
During the past 3 years, the average EBITDA Per Share Growth Rate was 31.30% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was -16.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 9 years, the highest 3-Year average EBITDA Per Share Growth Rate of Chill Brands Group was 70.90% per year. The lowest was -115.20% per year. And the median was 19.40% per year.
Chill Brands Group (LSE:CHLL) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Chill Brands Group 3-Year EBITDA Growth Rate Related Terms
LSE:CHLL vs ZTS, UTHR, VTRS: 3-Year EBITDA Growth Rate Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Chill Brands Group's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chill Brands Group 3-Year EBITDA Growth Rate vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Chill Brands Group's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Chill Brands Group's 3-Year EBITDA Growth Rate falls into.
Chill Brands Group 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 31.30% mean?
Chill Brands Group (LSE:CHLL) has a 3-Year EBITDA Growth Rate of 31.30% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Chill Brands Group and its competitors. This is 61% above median its historical median of 19.40. According to the industry distribution chart, Chill Brands Group ranks #167 out of 808 companies in the Drug Manufacturers industry, placing it in the top 20.7%.
Is Chill Brands Group's 3-Year EBITDA Growth Rate too high?
Chill Brands Group's current 3-Year EBITDA Growth Rate of 31.30% is 61% above median its 10-year median of 19.40. The Drug Manufacturers industry median 3-Year EBITDA Growth Rate is 8.80. Chill Brands Group's value of 31.30% is 255.7% above this industry median. Based on the distribution chart, Chill Brands Group ranks #167 out of 808 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Chill Brands Group's 3-Year EBITDA Growth Rate compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Chill Brands Group ranks #167 out of 808 companies for 3-Year EBITDA Growth Rate. This places Chill Brands Group in the top 21% of its industry — outperforming the majority of peers. The industry median 3-Year EBITDA Growth Rate is 8.80. Chill Brands Group's value of 31.30% is 255.7% above this benchmark. While the company's 10-year median is 19.40 vs. the industry median of 8.80, Chill Brands Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Drug Manufacturers company?
The median 3-Year EBITDA Growth Rate among Drug Manufacturers companies is 8.80, based on 808 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chill Brands Group's current 3-Year EBITDA Growth Rate of 31.30% is 255.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Chill Brands Group and its competitors. For the Drug Manufacturers industry, the median 3-Year EBITDA Growth Rate is 8.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chill Brands Group's current 3-Year EBITDA Growth Rate is 31.30%, which is 61% above median its own 10-year median of 19.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chill Brands Group stock overvalued right now?
Chill Brands Group (LSE:CHLL) has a current 3-Year EBITDA Growth Rate of 31.30%. The current 3-Year EBITDA Growth Rate is 31.30%, which is 61% above median its 10-year median of 19.40 and 255.7% above the Drug Manufacturers industry median of 8.80. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Chill Brands Group (LSE:CHLL), the current 3-Year EBITDA Growth Rate is 31.30% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Chill Brands Group PLC is a distribution-led consumer packaged goods company mainly serving the UK convenience retail sector. Through its chill connect platform, the company provides direct-to-store distribution and advisory services to brands seeking to expand their distribution into the independent convenience channel. Its product range spans vaping and nicotine alternatives, with active expansion into sundries, beverages, confectionery, and other fast-moving consumer goods. The company also owns the chill.com domain name, which operates as a marketplace for wellness and other consumer products. Geographically, it operates in the United Kingdom (its key revenue-generating market) and the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:CHLL has been successfully added to your 
